Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
A.C.T. Holdings, Inc.
Nuclear transfer technology firm reports files Form 10-QSB with U.S. SEC
July 6th, 2005
A.C.T. Holdings, Inc., (ACTH) and its wholly-owned subsidiary, Advanced Cell Technology, Inc., (ACT) announced that the company has filed Form 10-QSB with the U.S. Securities and Exchange Commission (SEC) releasing results of operations for the 3 months ended March 31, 2005. In addition, the Form 10-QSB includes additional disclosure about ACT, including an overview of its business and the field of regenerative medicine, a description of technology and research programs and an overview of the intellectual property portfolio. "We have chosen to expand the Form 10-QSB to provide the public and the investing community with more information about ACT,...
Source: Biotech Week (2005-07-06)
|
